220
Participants
Start Date
July 7, 2010
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2026
Biospecimen Collection
Undergo blood sample collection
Selumetinib
Given PO
Memorial Sloan Kettering Cancer Center, New York
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Children's National Medical Center, Washington D.C.
National Institutes of Health Clinical Center, Bethesda
Duke University Medical Center, Durham
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Saint Jude Children's Research Hospital, Memphis
Cincinnati Children's Hospital Medical Center, Cincinnati
Lurie Children's Hospital-Chicago, Chicago
Children's Memorial Outpatient Center in Lincoln Park, Chicago
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Texas Children's Hospital, Houston
Children's Hospital Colorado, Aurora
Children's Hospital Los Angeles, Los Angeles
UCSF Medical Center-Mount Zion, San Francisco
UCSF Medical Center-Parnassus, San Francisco
Lucile Packard Children's Hospital Stanford University, Palo Alto
National Cancer Institute (NCI)
NIH